EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
×
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)
QQQ   280.57 (-0.76%)
AAPL   141.17 (-2.11%)
MSFT   240.33 (-0.59%)
META   109.46 (+0.63%)
GOOGL   95.19 (-0.90%)
AMZN   92.42 (-1.63%)
TSLA   180.83 (-1.14%)
NVDA   156.39 (-1.19%)
NIO   10.50 (+3.75%)
BABA   79.86 (+5.25%)
AMD   73.39 (+0.27%)
T   19.01 (+1.01%)
MU   55.12 (-1.13%)
CGC   3.42 (+0.59%)
F   13.75 (+0.15%)
GE   85.66 (+0.22%)
DIS   94.69 (-1.05%)
AMC   7.43 (+1.36%)
PYPL   77.64 (-2.87%)
PFE   49.49 (-0.16%)
NFLX   280.96 (-0.07%)

Lifesci Capital Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Lifesci Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Lifesci Capital.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
11/8/2022Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLow
Oyster Point Pharma, Inc. stock logo
OYST
Oyster Point Pharma
11/7/2022Reiterated byLifesci CapitalAnalyst Patrick DolezalOutperform -> Market Perform $12.00Low
CinCor Pharma, Inc. stock logo
CINC
CinCor Pharma
9/26/2022Initiated byLifesci CapitalOutperform $64.00Low
Renovacor, Inc. stock logo
RCOR
Renovacor
9/20/2022Downgraded byLifesci CapitalAnalyst P. DolezalOutperform -> Market PerformLow
Akili, Inc. stock logo
AKLI
Akili
9/6/2022Reiterated byLifesci CapitalAnalyst R. RakhitOutperformLow
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
8/12/2022Downgraded byLifesci CapitalAnalyst P. DolezalOutperform -> Market PerformLow
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
8/12/2022Upgraded byLifesci CapitalAnalyst P. DolezalMarket Perform -> OutperformLow
Renovacor, Inc. stock logo
RCOR
Renovacor
6/16/2022Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLow
Tenaya Therapeutics, Inc. stock logo
TNYA
Tenaya Therapeutics
6/16/2022Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLow
Pear Therapeutics, Inc. stock logo
PEAR
Pear Therapeutics
6/16/2022Reiterated byLifesci CapitalAnalyst R. RakhitOutperformLow
VERA
Vera Therapeutics
3/28/2022Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLow
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
3/25/2022Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformMedium
Lucira Health, Inc. stock logo
LHDX
Lucira Health
3/22/2022Upgraded byLifesci CapitalAnalyst R. RakhitMarket Perform -> OutperformLow
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
2/16/2022Downgraded byLifesci CapitalAnalyst Patrick DolezalOutperform -> Market Perform $3.00Medium
Better Therapeutics, Inc. stock logo
BTTX
Better Therapeutics
12/27/2021Reiterated byLifesci CapitalAnalyst R. RakhitOutperformHigh
Verve Therapeutics, Inc. stock logo
VERV
Verve Therapeutics
12/22/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHigh
Allakos Inc. stock logo
ALLK
Allakos
12/22/2021Downgraded byLifesci CapitalAnalyst S. SlutskyOutperform -> Market PerformHigh
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
11/17/2021Downgraded byLifesci CapitalAnalyst R. RakhitOutperform -> Market PerformLow
Ventyx Biosciences, Inc. stock logo
VTYX
Ventyx Biosciences
11/15/2021Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHigh
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
11/4/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMedium
Aeglea BioTherapeutics, Inc. stock logo
AGLE
Aeglea BioTherapeutics
11/5/2021Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLow
Pyxis Oncology, Inc. stock logo
PYXS
Pyxis Oncology
11/2/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLow
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
10/24/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLow
DarioHealth Corp. stock logo
DRIO
DarioHealth
8/26/2021Reiterated byLifesci CapitalAnalyst R. RakhitOutperformHigh
Viridian Therapeutics, Inc. stock logo
VRDN
Viridian Therapeutics
8/24/2021Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformLow
Lucira Health, Inc. stock logo
LHDX
Lucira Health
8/13/2021Downgraded byLifesci CapitalAnalyst D. ShermanOutperform -> Market PerformMedium
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
8/4/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMedium
Olema Pharmaceuticals, Inc. stock logo
OLMA
Olema Pharmaceuticals
6/21/2021Reiterated byLifesci CapitalAnalyst A. EverttsOutperformHigh
Nano-X Imaging Ltd. stock logo
NNOX
Nano-X Imaging
6/3/2021Reiterated byLifesci CapitalAnalyst R. RakhitOutperformHigh
VectivBio Holding AG stock logo
VECT
VectivBio
5/4/2021Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHigh
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
4/29/2021Downgraded byLifesci CapitalAnalyst P. DolezalOutperform -> Market PerformHigh
Eledon Pharmaceuticals, Inc. stock logo
ELDN
Eledon Pharmaceuticals
3/18/2021Reiterated byLifesci CapitalAnalyst R. KatkhudaOutperformHigh
Lucira Health, Inc. stock logo
LHDX
Lucira Health
3/2/2021Reiterated byLifesci CapitalAnalyst D. ShermanOutperformHigh
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
1/4/2021Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformN/A
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
11/17/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHigh
BELLUS Health Inc. stock logo
BLU
BELLUS Health
11/12/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformN/A
BELLUS Health Inc. stock logo
BLU
BELLUS Health
11/12/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformMedium
Tarsus Pharmaceuticals, Inc. stock logo
TARS
Tarsus Pharmaceuticals
11/10/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMedium
Avadel Pharmaceuticals plc stock logo
AVDL
Avadel Pharmaceuticals
11/9/2020Reiterated byLifesci CapitalAnalyst D. ShermanOutperformLow
Catalyst Biosciences, Inc. stock logo
CBIO
Catalyst Biosciences
11/5/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHigh
Adverum Biotechnologies, Inc. stock logo
ADVM
Adverum Biotechnologies
11/5/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMedium
InflaRx stock logo
IFRX
InflaRx
10/30/2020Reiterated byLifesci CapitalAnalyst S. SlutskyMarket PerformLow
Oyster Point Pharma, Inc. stock logo
OYST
Oyster Point Pharma
10/27/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMedium
Aeglea BioTherapeutics, Inc. stock logo
AGLE
Aeglea BioTherapeutics
10/23/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformMedium
Allakos Inc. stock logo
ALLK
Allakos
10/22/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformLow
MEI Pharma, Inc. stock logo
MEIP
MEI Pharma
10/21/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMedium
Rocket Pharmaceuticals, Inc. stock logo
RCKT
Rocket Pharmaceuticals
10/16/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformLow
Inhibrx, Inc. stock logo
INBX
Inhibrx
10/15/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformMedium
Immunovant, Inc. stock logo
IMVT
Immunovant
10/6/2020Reiterated byLifesci CapitalAnalyst S. SlutskyOutperformHigh
VYNE Therapeutics Inc. stock logo
VYNE
VYNE Therapeutics
10/2/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformHigh
CymaBay Therapeutics, Inc. stock logo
CBAY
CymaBay Therapeutics
9/29/2020Reiterated byLifesci CapitalAnalyst P. DolezalOutperformMedium
ALX Oncology Holdings Inc. stock logo
ALXO
ALX Oncology
9/30/2020Reiterated byLifesci CapitalAnalyst A. EverttsOutperformLow
Cortexyme, Inc. stock logo
CRTX
Cortexyme
9/24/2020Reiterated byLifesci CapitalAnalyst D. ShermanOutperformHigh

MarketBeat Community Rating for Lifesci Capital

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  83 (Vote Outperform)
Underperform Votes:  79 (Vote Underperform)
Total Votes:  162
MarketBeat's community ratings are surveys of what our community members think about Lifesci Capital and other research firms. Vote "Outperform" if you believe Lifesci Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Lifesci Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools